Goodwin Procter·FDA / LIFE SCIENCES REGULATORY

FDA-SEC MOU Enables Broader Nonpublic Information Sharing

The FDA and SEC's new August 2026 MOU formalizes information sharing, allowing the SEC to use nonpublic FDA data in public company filing reviews and enforcement actions.

fda-sec-mouinteragency-collaborationnonpublic-information-sharingpublic-company-disclosureenforcement-referrallife-sciences-regulation
Read the original firm alert → Saturday, September 12, 2026

Stay ahead

Join the digest.

One email when the daily AmLaw 100 briefing ships. No noise, no pitch decks — just the grade 4–5 signal.